Axonics

Axonics, Inc. is a medical technology company based in Irvine, California, founded in 2012. As a subsidiary of Boston Scientific Corporation since November 2024, Axonics focuses on developing and commercializing innovative implantable neuromodulation products for treating bladder and bowel dysfunction in adults. The company specializes in sacral neuromodulation (SNM) systems, including the rechargeable Axonics R20 and the recharge-free Axonics F15, which help alleviate symptoms of overactive bladder, fecal incontinence, and urinary retention. Additionally, Axonics offers Bulkamid, a urethral bulking agent for treating female stress urinary incontinence, along with patient remote controls and wireless charging systems to enhance user convenience. Axonics markets its products through a direct sales force and distributors in various countries, including the United States, the United Kingdom, and Australia. The company is committed to improving patients' quality of life and advancing treatment options in the field of urology.